Mutoni Jean d'Amour, Coutelier Jean-Paul, Rujeni Nadine, Mutesa Leon, Cani Patrice D
Biomedical Laboratory Sciences Department, College of Medicine and Health Sciences, University of Rwanda, Kigali P.O. Box 3286, Rwanda.
De Duve Institute, Université Catholique de Louvain (UCLouvain), 1200 Brussels, Belgium.
Microorganisms. 2022 Mar 27;10(4):721. doi: 10.3390/microorganisms10040721.
Malaria, caused by the species, is an infectious disease responsible for more than 600 thousand deaths and more than 200 million morbidity cases annually. With above 90% of those deaths and cases, sub-Saharan Africa is affected disproportionately. Malaria clinical manifestations range from asymptomatic to simple, mild, and severe disease. External factors such as the gut microbiota and helminthiases have been shown to affect malaria clinical manifestations. However, little is known about whether the gut microbiota has the potential to influence malaria clinical manifestations in humans. Similarly, many previous studies have shown divergent results on the effects of helminths on malaria clinical manifestations. To date, a few studies, mainly murine, have shown the gut microbiota's capacity to modulate malaria's prospective risk of infection, transmission, and severity. This short review seeks to summarize recent literature about possible interactions between malaria, helminthiases, and the gut microbiota. The knowledge from this exercise will inform innovation possibilities for future tools, technologies, approaches, and policies around the prevention and management of malaria in endemic countries.
由疟原虫属物种引起的疟疾是一种传染病,每年导致超过60万人死亡,发病病例超过2亿例。其中90%以上的死亡和病例集中在撒哈拉以南非洲地区,该地区受到的影响尤为严重。疟疾的临床表现从无症状到轻症、重症不等。肠道微生物群和蠕虫感染等外部因素已被证明会影响疟疾的临床表现。然而,关于肠道微生物群是否有可能影响人类疟疾的临床表现,人们知之甚少。同样,之前许多研究对于蠕虫对疟疾临床表现的影响也得出了不同的结果。迄今为止,一些主要以小鼠为研究对象的研究表明,肠道微生物群有能力调节疟疾感染、传播和严重程度的潜在风险。这篇简短的综述旨在总结近期有关疟疾、蠕虫感染和肠道微生物群之间可能存在的相互作用的文献。从这项研究中获得的知识将为流行国家未来围绕疟疾预防和管理的工具、技术、方法及政策的创新提供思路。